IE39410L - Anesthetic compositions and their use - Google Patents
Anesthetic compositions and their useInfo
- Publication number
- IE39410L IE39410L IE741211A IE121174A IE39410L IE 39410 L IE39410 L IE 39410L IE 741211 A IE741211 A IE 741211A IE 121174 A IE121174 A IE 121174A IE 39410 L IE39410 L IE 39410L
- Authority
- IE
- Ireland
- Prior art keywords
- anesthetic compositions
- desoxytetrodotoxin
- tetrodotoxin
- micrograms
- amount
- Prior art date
Links
- 230000003444 anaesthetic effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- COVOMQKTVSVWBZ-CJCGOCGYSA-N deoxytetrodotoxin Chemical compound O1C(C2(O)CO)(O)OC3C(O)C1[C@@H]1CN=C(N)NC12C3O COVOMQKTVSVWBZ-CJCGOCGYSA-N 0.000 abstract 2
- CFMYXEVWODSLAX-QOZOJKKESA-N tetrodotoxin Chemical compound O([C@@]([C@H]1O)(O)O[C@H]2[C@@]3(O)CO)[C@H]3[C@@H](O)[C@]11[C@H]2[C@@H](O)N=C(N)N1 CFMYXEVWODSLAX-QOZOJKKESA-N 0.000 abstract 2
- 229950010357 tetrodotoxin Drugs 0.000 abstract 2
- CFMYXEVWODSLAX-UHFFFAOYSA-N tetrodotoxin Natural products C12C(O)NC(=N)NC2(C2O)C(O)C3C(CO)(O)C1OC2(O)O3 CFMYXEVWODSLAX-UHFFFAOYSA-N 0.000 abstract 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Vertebrates can be anesthetized regionally by a subarachnoid administration of tetrodotoxin or desoxytetrodotoxin. The amount of tetrodotoxin which should be administered in a preferred embodiment ranges between 1 and 12 micrograms, whereas the amount of desoxytetrodotoxin ranges between 10 and 120 micrograms.
[US3898339A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US388147A US3898339A (en) | 1973-08-14 | 1973-08-14 | Spinal anesthesia using small amounts of tetrodotoxin or desoxytetrodotoxin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE39410L true IE39410L (en) | 1975-02-14 |
| IE39410B1 IE39410B1 (en) | 1978-09-27 |
Family
ID=23532901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1211/74A IE39410B1 (en) | 1973-08-14 | 1974-06-10 | Anesthetic compositions and their use |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3898339A (en) |
| JP (1) | JPS5048112A (en) |
| AT (1) | AT335616B (en) |
| BE (1) | BE816214A (en) |
| CA (1) | CA1027863A (en) |
| DD (1) | DD115035A5 (en) |
| DE (1) | DE2427732A1 (en) |
| ES (1) | ES427164A1 (en) |
| FR (1) | FR2240735B1 (en) |
| GB (1) | GB1453343A (en) |
| IE (1) | IE39410B1 (en) |
| LU (1) | LU70304A1 (en) |
| NL (1) | NL7407853A (en) |
| ZA (1) | ZA743765B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995024903A1 (en) * | 1994-03-17 | 1995-09-21 | Nanning Maple Leaf Pharmaceutical Co., Ltd. | The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence |
| CN1051706C (en) * | 1994-03-17 | 2000-04-26 | 南宁枫叶药业有限公司 | Amino hydrogenated quinazoline oxazoline compound and derivant thereof are guarded against the new purposes of falling drug dependence |
| US5585398A (en) * | 1994-07-15 | 1996-12-17 | Ernst; Amy A. | Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use |
| US5550049A (en) | 1994-11-10 | 1996-08-27 | Merck & Co., Inc | Process for identifying para cation channel modulators |
| WO1998043619A2 (en) * | 1997-04-02 | 1998-10-08 | The Regents Of The University Of California | Method of local anesthesia |
| CN1236773C (en) * | 2000-11-22 | 2006-01-18 | 南宁枫叶药业有限公司 | Preparation for analgesia and anesthesia or curing drug dependence |
| WO2006032459A1 (en) * | 2004-09-22 | 2006-03-30 | Laboratorios Del Dr. Esteve S.A. | Tetrodotoxin and its derivatives for the treatment of peripheral-nervously derived neuropathic pain |
| EP1931349A4 (en) * | 2005-08-25 | 2009-08-05 | Wex Pharmaceuticals Inc | Use of sodium channel blockers for the management of musculoskeletal pain |
| EP2394646B1 (en) * | 2006-03-27 | 2018-07-25 | Wex Medical Limited | Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy |
-
1973
- 1973-08-14 US US388147A patent/US3898339A/en not_active Expired - Lifetime
-
1974
- 1974-06-08 DE DE19742427732 patent/DE2427732A1/en active Pending
- 1974-06-10 IE IE1211/74A patent/IE39410B1/en unknown
- 1974-06-11 FR FR7420219A patent/FR2240735B1/fr not_active Expired
- 1974-06-11 ES ES427164A patent/ES427164A1/en not_active Expired
- 1974-06-12 NL NL7407853A patent/NL7407853A/en unknown
- 1974-06-12 LU LU70304A patent/LU70304A1/xx unknown
- 1974-06-12 DD DD179117A patent/DD115035A5/xx unknown
- 1974-06-12 JP JP49067020A patent/JPS5048112A/ja active Pending
- 1974-06-12 BE BE145320A patent/BE816214A/en unknown
- 1974-06-12 AT AT484974A patent/AT335616B/en not_active IP Right Cessation
- 1974-06-12 CA CA202,294A patent/CA1027863A/en not_active Expired
- 1974-06-12 GB GB2609474A patent/GB1453343A/en not_active Expired
- 1974-06-12 ZA ZA00743765A patent/ZA743765B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATA484974A (en) | 1976-07-15 |
| ZA743765B (en) | 1975-06-25 |
| DD115035A5 (en) | 1975-09-12 |
| AU6993474A (en) | 1975-12-11 |
| GB1453343A (en) | 1976-10-20 |
| FR2240735B1 (en) | 1978-07-28 |
| CA1027863A (en) | 1978-03-14 |
| DE2427732A1 (en) | 1975-02-27 |
| LU70304A1 (en) | 1976-04-13 |
| IE39410B1 (en) | 1978-09-27 |
| NL7407853A (en) | 1975-02-18 |
| BE816214A (en) | 1974-12-12 |
| AT335616B (en) | 1977-03-25 |
| FR2240735A1 (en) | 1975-03-14 |
| US3898339A (en) | 1975-08-05 |
| ES427164A1 (en) | 1976-10-01 |
| JPS5048112A (en) | 1975-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8402155A1 (en) | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose | |
| IE39410L (en) | Anesthetic compositions and their use | |
| UA40636C2 (en) | pharmaceutical composition containing, as the active ingredient, an association of acetylsalicylic acid and metoclopramide, pharmaceutical medication in the form of powder and method for its preparation | |
| AU566228B2 (en) | Compressed hydroxybutryic acid polymer retarded release vehicle | |
| GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
| CA2047802A1 (en) | Pharmaceutical compositions | |
| IE42951L (en) | Injectable antibiotics compositions | |
| IL127851A0 (en) | Inhibition of TNF activity | |
| AU476979B2 (en) | 4'-alkoxyalkyleneoxy-5-benzylpyrimidines, their preparation and pharmaceutical compositions thereof | |
| CA983850A (en) | Pharmaceutical compositions containing a local anaesthetic, tetrodotoxin and desoxytetrodotoxin | |
| GB1435685A (en) | Hydroxyl-subst | |
| GR3004113T3 (en) | ||
| AU476623B2 (en) | 3 7-hydroxy-19-nor-5d-pregnane-11, 20-dione and pharmaceutical compositions thereof | |
| IE781283L (en) | Sulphonamide-containing pharmaceutical composition | |
| GB1290300A (en) | ||
| GB1446237A (en) | Pharmaceutical preparations containing pyrazolones | |
| GB1440832A (en) | Pharmaceutical preparation comprising antibiotics | |
| GB1449043A (en) | Treatment of asthma | |
| GB1463908A (en) | 1-dimethylamino-methyl-6-substituted-4h-s-triazolo-4,3-a- 1,4-benzodiazepine | |
| GB1265114A (en) | ||
| GR3003678T3 (en) | ||
| IL46346A (en) | Pharmaceutical compositions having synergistic analgesic activity comprising a 14-hydroxyazidomorphine derivative and a 1,6-dialkyl-4-oxohompyrimidazole-3-carboxylic acid derivative | |
| GB1287433A (en) | Pharmaceutical compositions | |
| IE36809L (en) | Glucocorticoid-like water diuretic. | |
| AU484787B2 (en) | Substituted 1, 3-diphenyltriazines and pharmaceutical compositions thereof |